Teva Pharmaceuticals Competitors and Similar CompaniesClear all
Teva Pharmaceuticals's competitors and similar companies include Viatris, WuXi AppTec and Pfizer.
 Viatris Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products. |  WuXi AppTec WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. | ||
Founding Date | Founding Date 1901 | Founding Date 2020 | Founding Date 2000 | Founding Date 1849 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more | Locations Canonsburg, US HQ Carole Park, AU Millers Point, AU Campos Dos Goytacazes, BR São Paulo, BR Sofia, BG Toronto, CA see more | Locations Shanghai, CN HQ Beijing, CN Changzhou, CN Chengdu, CN Nanjing, CN Nantong, CN Shanghai, CN see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more |
Employees | Employees 37,000 | Employees 38,0003% increase | Employees 39,414 | Employees 81,0008% decrease |
Valuation ($) | Valuation ($) 20.8 b | Valuation ($) 14 b | Valuation ($) 20.7 b | Valuation ($) 163.9 b |
Financial | ||||
Revenue (est.) | Revenue (est.) $17.3b (FY, 2025) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) ¥43.1b (FY, 2025) | Revenue (est.) $62.6b (FY, 2025) |
Cost of goods | Cost of goods $8.3b (FY, 2025) | Cost of goods $9.3b (FY, 2025) | Cost of goods ¥23.8b (FY, 2025) | Cost of goods $16.1b (FY, 2025) |
Gross profit | Gross profit $8.9b (FY, 2025) | Gross profit $5b (FY, 2025) | Gross profit ¥21.3b (FY, 2025) | Gross profit $46.5b (FY, 2025) |
Net income | Net income $1.4b (FY, 2025) | Net income ($3.5b) (FY, 2025) | Net income ¥19.3b (FY, 2025) | Net income $7.8b (FY, 2025) |
Operating ⚠ | ||||
Countries | Countries N/A | Countries 165 (Q1, 2023) | Countries N/A | Countries 200 (FY, 2024) |
Manufacturing Sites | Manufacturing Sites N/A | Manufacturing Sites 40 (Q1, 2023) | Manufacturing Sites N/A | Manufacturing Sites 37 (FY, 2024) |
Molecules | Molecules N/A | Molecules 1.4 k (Q1, 2023) | Molecules 2.8 k (H1, 2023) | Molecules N/A |
Funding | ||||
Total funding raised | Total funding raised $ 358m | Total funding raised N/A | Total funding raised $ 902.6m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Viatris
HQ
Canonsburg, US
Employees
38,000↑ 3% increase
Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products.
View companyWuXi AppTec
HQ
Shanghai, CN
Employees
39,414
WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production.
View companyPfizer
HQ
New York, US
Employees
81,000↓ 8% decrease
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View company